Sirpa Jalkanen - Publications

Stanford 83-86 
Cell trafficking, tumor immunity

253 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Cao Y, Yang J, Eichin D, Zhao F, Qi D, Kahari L, Jia C, Peurla M, Rosenholm JM, Zhao Z, Jalkanen S, Li J. Self-Synthesizing Nanorods from Dynamic Combinatorial Libraries against Drug Resistant Cancer. Angewandte Chemie (International Ed. in English). PMID 33112477 DOI: 10.1002/anie.202010937  0.44
2020 Takeda A, Jalkanen S. Single-Cell Transcriptomics of Human Lymph Node Stroma. Star Protocols. 1: 100021. PMID 33111075 DOI: 10.1016/j.xpro.2020.100021  0.92
2020 Ruotsalainen SE, Partanen JJ, Cichonska A, Lin J, Benner C, Surakka I, Reeve MP, Palta P, Salmi M, Jalkanen S, Ahola-Olli A, Palotie A, Salomaa V, Daly MJ, et al. An expanded analysis framework for multivariate GWAS connects inflammatory biomarkers to functional variants and disease. European Journal of Human Genetics : Ejhg. PMID 33110245 DOI: 10.1038/s41431-020-00730-8  1
2020 Eichin D, Pessia A, Takeda A, Laakkonen J, Bellmann L, Kankainen M, Imhof BA, Stoitzner P, Tang J, Salmi M, Jalkanen S. CD73 contributes to anti-inflammatory properties of afferent lymphatic endothelial cells in humans and mice. European Journal of Immunology. PMID 32970335 DOI: 10.1002/eji.201948432  1
2020 Junttila A, Helminen O, Väyrynen JP, Ahtiainen M, Kenessey I, Jalkanen S, Mecklin JP, Kellokumpu I, Kuopio T, Böhm J, Mrena J. Immunophenotype based on inflammatory cells, PD-1/PD-L1 signalling pathway and M2 macrophages predicts survival in gastric cancer. British Journal of Cancer. PMID 32943749 DOI: 10.1038/s41416-020-01053-7  1
2020 Maurel M, Castagné R, Berger E, Bochud M, Chadeau-Hyam M, Fraga S, Gandini M, Hutri-Kähönen N, Jalkanen S, Kivimäki M, Marmot M, McCrory C, Preisig M, Raitakari O, Ricceri F, et al. Patterning of educational attainment across inflammatory markers: findings from a multi-cohort study. Brain, Behavior, and Immunity. PMID 32919037 DOI: 10.1016/j.bbi.2020.09.002  1
2020 Jargaud V, Bour S, Tercé F, Collet X, Valet P, Bouloumié A, Guillemot JC, Mauriège P, Jalkanen S, Stolen C, Salmi M, Smith DJ, Carpéné C. Obesity of mice lacking VAP-1/SSAO by Aoc3 gene deletion is reproduced in mice expressing a mutated vascular adhesion protein-1 (VAP-1) devoid of amine oxidase activity. Journal of Physiology and Biochemistry. PMID 32712883 DOI: 10.1007/s13105-020-00756-y  1
2020 Tahkola K, Ahtiainen M, Kellokumpu I, Mecklin JP, Laukkarinen J, Laakkonen J, Kenessey I, Jalkanen S, Salmi M, Böhm J. Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer. Virchows Archiv : An International Journal of Pathology. PMID 32676968 DOI: 10.1007/s00428-020-02888-4  1
2020 Hollmén M, Figueiredo CR, Jalkanen S. New tools to prevent cancer growth and spread: a 'Clever' approach. British Journal of Cancer. PMID 32595212 DOI: 10.1038/s41416-020-0953-0  1
2020 Jalkanen J, Hollmén M, Jalkanen S. Interferon beta-1a for COVID-19: critical importance of the administration route. Critical Care (London, England). 24: 335. PMID 32532353 DOI: 10.1186/s13054-020-03048-5  1
2020 Jalkanen J, Pettilä V, Huttunen T, Hollmén M, Jalkanen S. Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung. Intensive Care Medicine. PMID 32430515 DOI: 10.1007/s00134-020-06086-3  1
2020 Xiang M, Grosso RA, Takeda A, Pan J, Bekkhus T, Brulois K, Dermadi D, Nordling S, Vanlandewijck M, Jalkanen S, Ulvmar MH, Butcher EC. A Single-Cell Transcriptional Roadmap of the Mouse and Human Lymph Node Lymphatic Vasculature. Frontiers in Cardiovascular Medicine. 7: 52. PMID 32426372 DOI: 10.3389/fcvm.2020.00052  1
2020 Losenkova K, Zuccarini M, Karikoski M, Laurila J, Boison D, Jalkanen S, Yegutkin GG. Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia. Journal of Cell Science. PMID 32317394 DOI: 10.1242/jcs.241463  1
2020 Jalkanen S, Salmi M. Lymphatic endothelial cells of the lymph node. Nature Reviews. Immunology. PMID 32094869 DOI: 10.1038/s41577-020-0281-x  1
2020 Ranieri VM, Pettilä V, Karvonen MK, Jalkanen J, Nightingale P, Brealey D, Mancebo J, Ferrer R, Mercat A, Patroniti N, Quintel M, Vincent JL, Okkonen M, Meziani F, Bellani G, ... ... Jalkanen S, et al. Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial. Jama. PMID 32065831 DOI: 10.1001/jama.2019.22525  1
2020 Losenkova K, Paul M, Irjala H, Jalkanen S, Yegutkin GG. Histochemical Approach for Simultaneous Detection of Ectonucleotidase and Alkaline Phosphatase Activities in Tissues. Methods in Molecular Biology (Clifton, N.J.). 2041: 107-116. PMID 31646483 DOI: 10.1007/978-1-4939-9717-6_7  1
2019 Elo P, Li XG, Liljenbäck H, Helin S, Teuho J, Koskensalo K, Saunavaara V, Marjamäki P, Oikonen V, Virta J, Chen Q, Low PS, Knuuti J, Jalkanen S, Airas L, et al. Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats. Journal of Neuroinflammation. 16: 252. PMID 31796042 DOI: 10.1186/s12974-019-1612-3  1
2019 Fair-Mäkelä R, Ugur M, Iftakhar-E-Khuda I, Kähäri L, Kukkonen-Macchi A, Brenyah HM, Elima K, Miyasaka M, Pabst O, Jalkanen S. Robo4 contributes to the turnover of Peyer's patch B cells. Mucosal Immunology. PMID 31772321 DOI: 10.1038/s41385-019-0230-9  0.88
2019 Nath AP, Ritchie SC, Grinberg NF, Tang HH, Huang QQ, Teo SM, Ahola-Olli AV, Würtz P, Havulinna AS, Santalahti K, Pitkänen N, Lehtimäki T, Kähönen M, Lyytikäinen LP, Raitoharju E, ... ... Jalkanen S, et al. Multivariate Genome-Wide Association Analysis of a Cytokine Network Reveals Variants with Widespread Immune, Haematological, and Cardiometabolic Pleiotropy. American Journal of Human Genetics. PMID 31679650 DOI: 10.1016/j.ajhg.2019.10.001  1
2019 Takeda A, Hollmén M, Dermadi D, Pan J, Brulois KF, Kaukonen R, Lönnberg T, Boström P, Koskivuo I, Irjala H, Miyasaka M, Salmi M, Butcher EC, Jalkanen S. Single-Cell Survey of Human Lymphatics Unveils Marked Endothelial Cell Heterogeneity and Mechanisms of Homing for Neutrophils. Immunity. PMID 31402260 DOI: 10.1016/j.immuni.2019.06.027  1
2019 Kähäri L, Fair-Mäkelä R, Auvinen K, Rantakari P, Jalkanen S, Ivaska J, Salmi M. Transcytosis route mediates rapid delivery of intact antibodies to draining lymph nodes. The Journal of Clinical Investigation. 129: 3086-3102. PMID 31232704 DOI: 10.1172/JCI125740  1
2019 Sliz E, Kalaoja M, Ahola-Olli A, Raitakari O, Perola M, Salomaa V, Lehtimäki T, Karhu T, Viinamäki H, Salmi M, Santalahti K, Jalkanen S, Jokelainen J, Keinänen-Kiukaanniemi S, Männikkö M, et al. Genome-wide association study identifies seven novel loci associating with circulating cytokines and cell adhesion molecules in Finns. Journal of Medical Genetics. 56: 607-616. PMID 31217265 DOI: 10.1136/jmedgenet-2018-105965  1
2019 Tadayon S, Dunkel J, Takeda A, Halle O, Karikoski M, Gerke H, Rantakari P, Virtakoivu R, Pabst O, Salmi M, Hollmén M, Jalkanen S. Clever-1 contributes to lymphocyte entry into the spleen via the red pulp. Science Immunology. 4. PMID 30926591 DOI: 10.1126/sciimmunol.aat0297  1
2019 Siitonen R, Peuhu E, Autio AK, Liljenbäck H, Mattila E, Metsälä O, Käkelä M, Saanijoki T, Dijkgraaf I, Jalkanen S, Ivaska J, Roivainen A. Ga-DOTA-E[c(RGDfK)] Positron Emission Tomography Imaging of SHARPIN-Regulated Integrin Activity in Mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30850498 DOI: 10.2967/jnumed.118.222026  0.68
2019 Viitala M, Virtakoivu R, Tadayon S, Rannikko J, Jalkanen S, Hollmén M. Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8 T-cell Response against Immunosuppressive Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 25: 3289-3303. PMID 30755440 DOI: 10.1158/1078-0432.CCR-18-3016  1
2019 Zeiner J, Loukovaara S, Losenkova K, Zuccarini M, Korhonen AM, Lehti K, Kauppinen A, Kaarniranta K, Müller CE, Jalkanen S, Yegutkin GG. Soluble and membrane-bound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage. Journal of Molecular Medicine (Berlin, Germany). 97: 341-354. PMID 30617853 DOI: 10.1007/s00109-018-01734-0  0.64
2019 Jalkanen J, Hollmén M, Maksimow M, Jalkanen S, Hakovirta H. Serum cytokine levels differ according to major cardiovascular risk factors in patients with lower limb atherosclerosis. Cytokine. 114: 74-80. PMID 30442459 DOI: 10.1016/j.cyto.2018.11.001  1
2019 Salmi M, Jalkanen S. Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation. Antioxidants & Redox Signaling. 30: 314-332. PMID 29065711 DOI: 10.1089/ars.2017.7418  1
2018 Koivisto M, Tervahartiala M, Kenessey I, Jalkanen S, Boström PJ, Salmi M. Cell-type specific CD73 expression is an independent prognostic factor in bladder cancer. Carcinogenesis. PMID 30395172 DOI: 10.1093/carcin/bgy154  1
2018 Dunkel J, Viitala M, Karikoski M, Rantakari P, Virtakoivu R, Elima K, Hollmén M, Jalkanen S, Salmi M. Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice. Frontiers in Immunology. 9: 2257. PMID 30349531 DOI: 10.3389/fimmu.2018.02257  1
2018 Munukka E, Ahtiainen JP, Puigbó P, Jalkanen S, Pahkala K, Keskitalo A, Kujala UM, Pietilä S, Hollmén M, Elo L, Huovinen P, D'Auria G, Pekkala S. Six-Week Endurance Exercise Alters Gut Metagenome That Is not Reflected in Systemic Metabolism in Over-weight Women. Frontiers in Microbiology. 9: 2323. PMID 30337914 DOI: 10.3389/fmicb.2018.02323  1
2018 Keskitalo A, Munukka E, Toivonen R, Hollmén M, Kainulainen H, Huovinen P, Jalkanen S, Pekkala S. Enterobacter cloacae administration induces hepatic damage and subcutaneous fat accumulation in high-fat diet fed mice. Plos One. 13: e0198262. PMID 29847581 DOI: 10.1371/journal.pone.0198262  1
2018 Elo P, Tadayon S, Liljenbäck H, Teuho J, Käkelä M, Koskensalo K, Saunavaara V, Virta J, Veres TZ, Kiviniemi A, Saraste A, Marjamäki P, Airas L, Jalkanen S, Roivainen A. Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis. Journal of Neuroinflammation. 15: 128. PMID 29716612 DOI: 10.1186/s12974-018-1152-2  1
2018 Jalkanen J, Hautero O, Maksimow M, Jalkanen S, Hakovirta H. Correlation between increasing tissue ischemia and circulating levels of angiogenic growth factors in peripheral artery disease. Cytokine. 110: 24-28. PMID 29689451 DOI: 10.1016/j.cyto.2018.04.012  1
2018 Losenkova K, Zuccarini M, Helenius M, Jacquemet G, Gerasimovskaya E, Tallgren C, Jalkanen S, Yegutkin GG. Endothelial cells cope with hypoxia-induced depletion of ATP via activation of cellular purine turnover and phosphotransfer networks. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 1864: 1804-1815. PMID 29514048 DOI: 10.1016/j.bbadis.2018.03.001  1
2018 Hagert C, Sareila O, Kelkka T, Nandakumar KS, Collin M, Xu B, Guérard S, Bäcklund J, Jalkanen S, Holmdahl R. Chronic active arthritis driven by macrophages without involvement of T cells. Arthritis & Rheumatology (Hoboken, N.J.). PMID 29513929 DOI: 10.1002/art.40482  0.44
2018 Hagert C, Sareila O, Kelkka T, Jalkanen S, Holmdahl R. The Macrophage Mannose Receptor Regulate Mannan-Induced Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis-Like Disease Models. Frontiers in Immunology. 9: 114. PMID 29467756 DOI: 10.3389/fimmu.2018.00114  0.44
2018 Lopes de Carvalho L, Elovaara H, de Ruyck J, Vergoten G, Jalkanen S, Guédez G, Salminen TA. Mapping the interaction site and effect of the Siglec-9 inflammatory biomarker on human primary amine oxidase. Scientific Reports. 8: 2086. PMID 29391504 DOI: 10.1038/s41598-018-20618-4  0.88
2018 Moisio O, Siitonen R, Liljenbäck H, Suomela E, Jalkanen S, Li XG, Roivainen A. Exploring Alternative Radiolabeling Strategies for Sialic Acid-Binding Immunoglobulin-Like Lectin 9 Peptide: [68Ga]Ga- and [18F]AlF-NOTA-Siglec-9. Molecules (Basel, Switzerland). 23. PMID 29385091 DOI: 10.3390/molecules23020305  1
2017 Virtanen H, Silvola JMU, Autio A, Li XG, Liljenbäck H, Hellberg S, Siitonen R, Ståhle M, Käkelä M, Airaksinen AJ, Helariutta K, Tolvanen T, Veres TZ, Saraste A, Knuuti J, ... Jalkanen S, et al. Comparison of Ga-DOTA-Siglec-9 and F-Fluorodeoxyribose-Siglec-9: Inflammation Imaging and Radiation Dosimetry. Contrast Media & Molecular Imaging. 2017: 7645070. PMID 29463960 DOI: 10.1155/2017/7645070  1
2017 Siitonen R, Pietikäinen A, Liljenbäck H, Käkelä M, Söderström M, Jalkanen S, Hytönen J, Roivainen A. Targeting of vascular adhesion protein-1 by positron emission tomography visualizes sites of inflammation in Borrelia burgdorferi-infected mice. Arthritis Research & Therapy. 19: 254. PMID 29166944 DOI: 10.1186/s13075-017-1460-4  1
2017 Tervahartiala M, Taimen P, Mirtti T, Koskinen I, Ecke T, Jalkanen S, Boström PJ. Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer. Scientific Reports. 7: 12682. PMID 28978923 DOI: 10.1038/s41598-017-12892-5  1
2017 Jensen SB, Käkelä M, Jødal L, Moisio O, Alstrup AKO, Jalkanen S, Roivainen A. Exploring the radiosynthesis and in vitro characteristics of [ Ga]Ga-DOTA-Siglec-9. Journal of Labelled Compounds & Radiopharmaceuticals. 60: 439-449. PMID 28556976 DOI: 10.1002/jlcr.3525  1
2017 Veres TZ, Kopcsányi T, Tirri M, Braun A, Miyasaka M, Germain RN, Jalkanen S, Salmi M. Intubation-free in vivo imaging of the tracheal mucosa using two-photon microscopy. Scientific Reports. 7: 694. PMID 28386104 DOI: 10.1038/s41598-017-00769-6  1
2017 Munukka E, Rintala A, Toivonen R, Nylund M, Yang B, Takanen A, Hänninen A, Vuopio J, Huovinen P, Jalkanen S, Pekkala S. Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice. The Isme Journal. PMID 28375212 DOI: 10.1038/ismej.2017.24  0.88
2017 Marttila-Ichihara F, Elima K, Auvinen K, Veres TZ, Rantakari P, Weston C, Miyasaka M, Adams D, Jalkanen S, Salmi M. Amine oxidase activity regulates the development of pulmonary fibrosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28251930 DOI: 10.1096/fj.201600935R  1
2017 Ahola-Olli AV, Würtz P, Havulinna AS, Aalto K, Pitkänen N, Lehtimäki T, Kähönen M, Lyytikäinen LP, Raitoharju E, Seppälä I, Sarin AP, Ripatti S, Palotie A, Perola M, Viikari JS, ... Jalkanen S, et al. Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors. American Journal of Human Genetics. 100: 40-50. PMID 27989323 DOI: 10.1016/j.ajhg.2016.11.007  1
2017 Jalkanen J, Hollmén M, Jalkanen S, Hakovirta H. Regulation of CD73 in the development of lower limb atherosclerosis. Purinergic Signalling. 13: 127-134. PMID 27832456 DOI: 10.1007/s11302-016-9545-0  1
2017 Loukovaara S, Sandholm J, Aalto K, Liukkonen J, Jalkanen S, Yegutkin GG. Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy. Journal of Molecular Medicine (Berlin, Germany). 95: 193-204. PMID 27638339 DOI: 10.1007/s00109-016-1472-6  1
2016 Wang Q, Würtz P, Auro K, Mäkinen VP, Kangas AJ, Soininen P, Tiainen M, Tynkkynen T, Jokelainen J, Santalahti K, Salmi M, Blankenberg S, Zeller T, Viikari J, Kähönen M, ... ... Jalkanen S, et al. Metabolic profiling of pregnancy: cross-sectional and longitudinal evidence. Bmc Medicine. 14: 205. PMID 27955712 DOI: 10.1186/s12916-016-0733-0  1
2016 Veres TZ, Kopcsányi T, van Panhuys N, Gerner MY, Liu Z, Rantakari P, Dunkel J, Miyasaka M, Salmi M, Jalkanen S, Germain RN. Allergen-Induced CD4+ T Cell Cytokine Production within Airway Mucosal Dendritic Cell-T Cell Clusters Drives the Local Recruitment of Myeloid Effector Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 27903737 DOI: 10.4049/jimmunol.1601448  1
2016 Elovaara H, Parkash V, Fair-Mäkelä R, Salo-Ahen OM, Guédez G, Bligt-Lindén E, Grönholm J, Jalkanen S, Salminen TA. Multivalent Interactions of Human Primary Amine Oxidase with the V and C22 Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase Activity. Plos One. 11: e0166935. PMID 27893774 DOI: 10.1371/journal.pone.0166935  0.88
2016 Patten DA, Wilson GK, Bailey D, Shaw RK, Jalkanen S, Salmi M, Rot A, Weston CJ, Adams DH, Shetty S. Human liver sinusoidal endothelial cells promote intracellular crawling of lymphocytes during recruitment- a new step in migration. Hepatology (Baltimore, Md.). PMID 27770554 DOI: 10.1002/hep.28879  1
2016 Vaara ST, Hollmén M, Korhonen AM, Maksimow M, Ala-Kokko T, Salmi M, Jalkanen S, Pettilä V. Soluble CD73 in Critically Ill Septic Patients - Data from the Prospective FINNAKI Study. Plos One. 11: e0164420. PMID 27732656 DOI: 10.1371/journal.pone.0164420  1
2016 Silvola JM, Virtanen H, Siitonen R, Hellberg S, Liljenbäck H, Metsälä O, Ståhle M, Saanijoki T, Käkelä M, Hakovirta H, Ylä-Herttuala S, Saukko P, Jauhiainen M, Veres TZ, Jalkanen S, et al. Leukocyte trafficking-associated vascular adhesion protein 1 is expressed and functionally active in atherosclerotic plaques. Scientific Reports. 6: 35089. PMID 27731409 DOI: 10.1038/srep35089  1
2016 Jalkanen J, Maksimow M, Hollmén M, Jalkanen S, Hakovirta H. Compared to Intermittant Claudication Critical Limb Ischemia Is Associated with Elevated Levels of Cytokines. Plos One. 11: e0162353. PMID 27611073 DOI: 10.1371/journal.pone.0162353  1
2016 Iftakhar-E-Khuda I, Fair-Mäkelä R, Kukkonen-Macchi A, Elima K, Karikoski M, Rantakari P, Miyasaka M, Salmi M, Jalkanen S. Gene-expression profiling of different arms of lymphatic vasculature identifies candidates for manipulation of cell traffic. Proceedings of the National Academy of Sciences of the United States of America. 113: 10643-8. PMID 27601677 DOI: 10.1073/pnas.1602357113  1
2016 Wang Q, Würtz P, Auro K, Morin-Papunen L, Kangas AJ, Soininen P, Tiainen M, Tynkkynen T, Joensuu A, Havulinna AS, Aalto K, Salmi M, Blankenberg S, Zeller T, Viikari J, ... ... Jalkanen S, et al. Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence. International Journal of Epidemiology. PMID 27538888 DOI: 10.1093/ije/dyw147  1
2016 Rantakari P, Patten DA, Valtonen J, Karikoski M, Gerke H, Dawes H, Laurila J, Ohlmeier S, Elima K, Hübscher SG, Weston CJ, Jalkanen S, Adams DH, Salmi M, Shetty S. Stabilin-1 expression defines a subset of macrophages that mediate tissue homeostasis and prevent fibrosis in chronic liver injury. Proceedings of the National Academy of Sciences of the United States of America. PMID 27474165 DOI: 10.1073/pnas.1604780113  0.8
2016 Laurila JP, Laukkanen MO, Joensuu H, Salmi M, Jalkanen S. Leukocyte trafficking is not affected by multikinase inhibitors Sunitinib or Sorafenib in mice. International Journal of Cancer. PMID 27459381 DOI: 10.1002/ijc.30285  1
2016 Santalahti K, Maksimow M, Airola A, Pahikkala T, Hutri-Kähönen N, Jalkanen S, Raitakari OT, Salmi M. Circulating Cytokines Predict the Development of Insulin Resistance in a Prospective Finnish Population Cohort. The Journal of Clinical Endocrinology and Metabolism. 101: 3361-9. PMID 27362289 DOI: 10.1210/jc.2016-2081  1
2016 Hollmén M, Karaman S, Schwager S, Lisibach A, Christiansen AJ, Maksimow M, Varga Z, Jalkanen S, Detmar M. G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer. Oncoimmunology. 5: e1115177. PMID 27141367 DOI: 10.1080/2162402X.2015.1115177  1
2016 Tuuminen R, Yegutkin GG, Jalkanen S, Loukovaara S. Simvastatin use associated with low intraocular ADP levels in patients with sight-threatening diabetic retinopathy. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 254: 1643-1644. PMID 27084086 DOI: 10.1007/s00417-016-3349-3  1
2016 Takeda A, Kobayashi D, Aoi K, Sasaki N, Sugiura Y, Igarashi H, Tohya K, Inoue A, Hata E, Akahoshi N, Hayasaka H, Kikuta J, Scandella E, Ludewig B, Ishii S, ... ... Jalkanen S, et al. Fibroblastic reticular cell-derived lysophosphatidic acid regulates confined intranodal T-cell motility. Elife. 5. PMID 26830463 DOI: 10.7554/eLife.10561  0.8
2016 Jalkanen J, Maksimow M, Jalkanen S, Hakovirta H. Hypoxia-induced inflammation and purinergic signaling in cross clamping the human aorta. Springerplus. 5: 2. PMID 26759741 DOI: 10.1186/s40064-015-1651-x  1
2016 Palani S, Elima K, Ekholm E, Jalkanen S, Salmi M. Monocyte Stabilin-1 Suppresses the Activation of Th1 Lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 196: 115-23. PMID 26608916 DOI: 10.4049/jimmunol.1500257  1
2016 Jadhav S, Käkelä M, Mäkilä J, Kiugel M, Liljenbäck H, Virta J, Poijärvi-Virta P, Laitala-Leinonen T, Kytö V, Jalkanen S, Saraste A, Roivainen A, Lönnberg H, Virta P. Synthesis and In Vivo PET Imaging of Hyaluronan Conjugates of Oligonucleotides. Bioconjugate Chemistry. 27: 391-403. PMID 26517303 DOI: 10.1021/acs.bioconjchem.5b00477  1
2016 Palani S, Elima K, Ekholm E, Jalkanen S, Salmi M. Monocyte stabilin-1 suppresses the activation of Th1 lymphocytes Journal of Immunology. 196: 115-123. DOI: 10.4049/jimmunol.1500257  0.8
2016 Hollmén M, Karaman S, Schwager S, Lisibach A, Christiansen AJ, Maksimow M, Varga Z, Jalkanen S, Detmar M. G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer Oncoimmunology. 5. DOI: 10.1080/2162402X.2015.1115177  0.8
2015 Ritchie SC, Würtz P, Nath AP, Abraham G, Havulinna AS, Fearnley LG, Sarin AP, Kangas AJ, Soininen P, Aalto K, Seppälä I, Raitoharju E, Salmi M, Maksimow M, Männistö S, ... ... Jalkanen S, et al. The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection. Cell Systems. 1: 293-301. PMID 27136058 DOI: 10.1016/j.cels.2015.09.007  1
2015 Elovaara H, Huusko T, Maksimow M, Elima K, Yegutkin GG, Skurnik M, Dobrindt U, Siitonen A, McPherson MJ, Salmi M, Jalkanen S. Primary Amine Oxidase of Escherichia coli Is a Metabolic Enzyme that Can Use a Human Leukocyte Molecule as a Substrate. Plos One. 10: e0142367. PMID 26556595 DOI: 10.1371/journal.pone.0142367  0.8
2015 Virtanen H, Autio A, Siitonen R, Liljenbäck H, Saanijoki T, Lankinen P, Mäkilä J, Käkelä M, Teuho J, Savisto N, Jaakkola K, Jalkanen S, Roivainen A. 68Ga-DOTA-Siglec-9--a new imaging tool to detect synovitis. Arthritis Research & Therapy. 17: 308. PMID 26530096 DOI: 10.1186/s13075-015-0826-8  1
2015 Eichin D, Laurila JP, Jalkanen S, Salmi M. CD73 Activity is Dispensable for the Polarization of M2 Macrophages. Plos One. 10: e0134721. PMID 26258883 DOI: 10.1371/journal.pone.0134721  1
2015 Boström MM, Irjala H, Mirtti T, Taimen P, Kauko T, Ålgars A, Jalkanen S, Boström PJ. Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer. Plos One. 10: e0133552. PMID 26197470 DOI: 10.1371/journal.pone.0133552  1
2015 Rantakari P, Auvinen K, Jäppinen N, Kapraali M, Valtonen J, Karikoski M, Gerke H, Iftakhar-E-Khuda I, Keuschnigg J, Umemoto E, Tohya K, Miyasaka M, Elima K, Jalkanen S, Salmi M. Erratum: The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes. Nature Immunology. 16: 544. PMID 25898202 DOI: 10.1038/ni0515-544c  1
2015 Rantakari P, Auvinen K, Jäppinen N, Kapraali M, Valtonen J, Karikoski M, Gerke H, Iftakhar-E-Khuda I, Keuschnigg J, Umemoto E, Tohya K, Miyasaka M, Elima K, Jalkanen S, Salmi M. The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes. Nature Immunology. 16: 386-96. PMID 25665101 DOI: 10.1038/ni.3101  1
2015 Jalkanen J, Yegutkin GG, Hollmén M, Aalto K, Kiviniemi T, Salomaa V, Jalkanen S, Hakovirta H. Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis. Circulation Research. 116: 1206-15. PMID 25645301 DOI: 10.1161/CIRCRESAHA.116.305715  1
2015 Weston CJ, Shepherd EL, Claridge LC, Rantakari P, Curbishley SM, Tomlinson JW, Hubscher SG, Reynolds GM, Aalto K, Anstee QM, Jalkanen S, Salmi M, Smith DJ, Day CP, Adams DH. Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis. The Journal of Clinical Investigation. 125: 501-20. PMID 25562318 DOI: 10.1172/JCI73722  0.8
2015 Yegutkin GG, Auvinen K, Rantakari P, Hollmén M, Karikoski M, Grénman R, Elima K, Jalkanen S, Salmi M. Ecto-5'-nucleotidase/CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature. European Journal of Immunology. 45: 562-73. PMID 25402681 DOI: 10.1002/eji.201444856  1
2015 Loukovaara S, Sahanne S, Jalkanen S, Yegutkin GG. Increased intravitreal adenosine 5'-triphosphate, adenosine 5'-diphosphate and adenosine 5'-monophosphate levels in patients with proliferative diabetic retinopathy. Acta Ophthalmologica. 93: 67-73. PMID 25079888 DOI: 10.1111/aos.12507  1
2015 Jalkanen S. Severity markers in acute pancreatitis Critical Care. 19: P389. DOI: 10.1186/cc14469  0.4
2015 Jalkanen S. New molecules controlling endothelial barrier Critical Care. 19: P234. DOI: 10.1186/cc14314  0.4
2015 Ritchie SC, Würtz P, Nath AP, Abraham G, Havulinna AS, Fearnley LG, Sarin AP, Kangas AJ, Soininen P, Aalto K, Seppälä I, Raitoharju E, Salmi M, Maksimow M, Männistö S, ... ... Jalkanen S, et al. The Biomarker GlycA is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection Cell Systems. 1: 293-301. DOI: 10.1016/j.cels.2015.09.007  0.8
2014 Ahtinen H, Kulkova J, Lindholm L, Eerola E, Hakanen AJ, Moritz N, Söderström M, Saanijoki T, Jalkanen S, Roivainen A, Aro HT. (68)Ga-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and staphylococcal infections. Ejnmmi Research. 4: 45. PMID 25520903 DOI: 10.1186/s13550-014-0045-3  1
2014 Karikoski M, Marttila-Ichihara F, Elima K, Rantakari P, Hollmén M, Kelkka T, Gerke H, Huovinen V, Irjala H, Holmdahl R, Salmi M, Jalkanen S. Clever-1/stabilin-1 controls cancer growth and metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6452-64. PMID 25320356 DOI: 10.1158/1078-0432.CCR-14-1236  1
2014 Yegutkin GG, Auvinen K, Karikoski M, Rantakari P, Gerke H, Elima K, Maksimow M, Quintero IB, Vihko P, Salmi M, Jalkanen S. Consequences of the lack of CD73 and prostatic acid phosphatase in the lymphoid organs. Mediators of Inflammation. 2014: 485743. PMID 25242869 DOI: 10.1155/2014/485743  1
2014 Metsola J, Maksimow M, Ojaniemi M, Metsola H, Marttila-Ichihara F, Vuolteenaho R, Yegutkin GG, Salmi M, Hallman M, Jalkanen S. Postnatal development and LPS responsiveness of pulmonary adenosine receptor expression and of adenosine-metabolizing enzymes in mice. Pediatric Research. 76: 515-21. PMID 25188742 DOI: 10.1038/pr.2014.132  1
2014 Maksimow M, Kyhälä L, Nieminen A, Kylänpää L, Aalto K, Elima K, Mentula P, Lehti M, Puolakkainen P, Yegutkin GG, Jalkanen S, Repo H, Salmi M. Early prediction of persistent organ failure by soluble CD73 in patients with acute pancreatitis*. Critical Care Medicine. 42: 2556-64. PMID 25126879 DOI: 10.1097/CCM.0000000000000550  1
2014 Dunkel J, Aguilar-Pimentel JA, Ollert M, Fuchs H, Gailus-Durner V, de Angelis MH, Jalkanen S, Salmi M, Veres TZ. Endothelial amine oxidase AOC3 transiently contributes to adaptive immune responses in the airways. European Journal of Immunology. 44: 3232-9. PMID 25116373 DOI: 10.1002/eji.201444563  1
2014 Virtanen SS, Kukkonen-Macchi A, Vainio M, Elima K, Härkönen PL, Jalkanen S, Yegutkin GG. Adenosine inhibits tumor cell invasion via receptor-independent mechanisms. Molecular Cancer Research : McR. 12: 1863-74. PMID 25080434 DOI: 10.1158/1541-7786.MCR-14-0302-T  0.88
2014 Lim ET, Würtz P, Havulinna AS, Palta P, Tukiainen T, Rehnström K, Esko T, Mägi R, Inouye M, Lappalainen T, Chan Y, Salem RM, Lek M, Flannick J, Sim X, ... ... Jalkanen S, et al. Distribution and medical impact of loss-of-function variants in the Finnish founder population. Plos Genetics. 10: e1004494. PMID 25078778 DOI: 10.1371/journal.pgen.1004494  0.8
2014 Aalto K, Havulinna AS, Jalkanen S, Salomaa V, Salmi M. Soluble vascular adhesion protein-1 predicts incident major adverse cardiovascular events and improves reclassification in a finnish prospective cohort study. Circulation. Cardiovascular Genetics. 7: 529-35. PMID 24850810 DOI: 10.1161/CIRCGENETICS.113.000543  1
2014 Auvinen K, Jalkanen S, Salmi M. Expression and function of endothelial selectins during human development. Immunology. 143: 406-15. PMID 24831412 DOI: 10.1111/imm.12318  1
2014 Kelkka T, Kienhöfer D, Hoffmann M, Linja M, Wing K, Sareila O, Hultqvist M, Laajala E, Chen Z, Vasconcelos J, Neves E, Guedes M, Marques L, Krönke G, Helminen M, ... ... Jalkanen S, et al. Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature. Antioxidants & Redox Signaling. 21: 2231-45. PMID 24787605 DOI: 10.1089/ars.2013.5828  0.44
2014 Bellingan G, Montgomery H, Maksimow M, Salmi M, Jalkanen S. Use of interferon beta for acute respiratory distress syndrome: proceed with caution--authors' reply. The Lancet. Respiratory Medicine. 2: e2-3. PMID 24717630 DOI: 10.1016/S2213-2600(14)70052-9  1
2014 Salmi M, Jalkanen S. Ectoenzymes in leukocyte migration and their therapeutic potential. Seminars in Immunopathology. 36: 163-76. PMID 24638888 DOI: 10.1007/s00281-014-0417-9  1
2014 Bellingan G, Maksimow M, Howell DC, Stotz M, Beale R, Beatty M, Walsh T, Binning A, Davidson A, Kuper M, Shah S, Cooper J, Waris M, Yegutkin GG, Jalkanen J, ... ... Jalkanen S, et al. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study. The Lancet. Respiratory Medicine. 2: 98-107. PMID 24503265 DOI: 10.1016/S2213-2600(13)70259-5  1
2014 Esser C, Bachmann A, Kuhn D, Schuldt K, Förster B, Thiel M, May J, Koch-Nolte F, Yáñez-Mó M, Sánchez-Madrid F, Schinkel AH, Jalkanen S, Craig AG, Bruchhaus I, Horstmann RD. Evidence of promiscuous endothelial binding by Plasmodium falciparum-infected erythrocytes. Cellular Microbiology. 16: 701-8. PMID 24444337 DOI: 10.1111/cmi.12270  0.8
2014 Schulz O, Ugur M, Friedrichsen M, Radulovic K, Niess JH, Jalkanen S, Krueger A, Pabst O. Hypertrophy of infected Peyer's patches arises from global, interferon-receptor, and CD69-independent shutdown of lymphocyte egress. Mucosal Immunology. 7: 892-904. PMID 24345804 DOI: 10.1038/mi.2013.105  0.48
2013 Kelkka T, Pizzolla A, Laurila JP, Friman T, Gustafsson R, Källberg E, Olsson O, Leanderson T, Rubin K, Salmi M, Jalkanen S, Holmdahl R. Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors. Plos One. 8: e84148. PMID 24358335 DOI: 10.1371/journal.pone.0084148  1
2013 Keuschnigg J, Karinen S, Auvinen K, Irjala H, Mpindi JP, Kallioniemi O, Hautaniemi S, Jalkanen S, Salmi M. Plasticity of blood- and lymphatic endothelial cells and marker identification. Plos One. 8: e74293. PMID 24058540 DOI: 10.1371/journal.pone.0074293  1
2013 Autio A, Vainio PJ, Suilamo S, Mali A, Vainio J, Saanijoki T, Noponen T, Ahtinen H, Luoto P, Teräs M, Jalkanen S, Roivainen A. Preclinical evaluation of a radioiodinated fully human antibody for in vivo imaging of vascular adhesion protein-1-positive vasculature in inflammation. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1315-9. PMID 23847292 DOI: 10.2967/jnumed.113.120295  0.8
2013 Kulesskaya N, Võikar V, Peltola M, Yegutkin GG, Salmi M, Jalkanen S, Rauvala H. CD73 is a major regulator of adenosinergic signalling in mouse brain. Plos One. 8: e66896. PMID 23776700 DOI: 10.1371/journal.pone.0066896  1
2013 Lee WY, Salmi M, Kelly MM, Jalkanen S, Kubes P. Therapeutic advantage of anti-VAP-1 over anti-α4 integrin antibody in concanavalin a-induced hepatitis. Hepatology (Baltimore, Md.). 58: 1413-23. PMID 23686782 DOI: 10.1002/hep.26469  0.8
2013 Salmi M, Karikoski M, Elima K, Rantakari P, Jalkanen S. CD44 binds to macrophage mannose receptor on lymphatic endothelium and supports lymphocyte migration via afferent lymphatics. Circulation Research. 112: 1577-82. PMID 23603511 DOI: 10.1161/CIRCRESAHA.111.300476  1
2013 Li XG, Autio A, Ahtinen H, Helariutta K, Liljenbäck H, Jalkanen S, Roivainen A, Airaksinen AJ. Translating the concept of peptide labeling with 5-deoxy-5-[18F]fluororibose into preclinical practice: 18F-labeling of Siglec-9 peptide for PET imaging of inflammation. Chemical Communications (Cambridge, England). 49: 3682-3684. PMID 23536117 DOI: 10.1039/c3cc40738a  1
2013 Kaitaniemi S, Grön K, Elovaara H, Salmi M, Jalkanen S, Elima K. Functional modulation of vascular adhesion protein-1 by a novel splice variant. Plos One. 8: e54151. PMID 23349812 DOI: 10.1371/journal.pone.0054151  1
2013 Mustjoki S, Auvinen K, Kreutzman A, Rousselot P, Hernesniemi S, Melo T, Lahesmaa-Korpinen AM, Hautaniemi S, Bouchet S, Molimard M, Smykla R, Lee FY, Vakkila J, Jalkanen S, Salmi M, et al. Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy. Leukemia. 27: 914-24. PMID 23192016 DOI: 10.1038/leu.2012.348  0.8
2012 Helenius M, Jalkanen S, Yegutkin G. Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids. Biochimica Et Biophysica Acta. 1823: 1967-75. PMID 22967714 DOI: 10.1016/j.bbamcr.2012.08.001  0.48
2012 Kiviniemi TO, Yegutkin GG, Toikka JO, Paul S, Aittokallio T, Janatuinen T, Knuuti J, Rönnemaa T, Koskenvuo JW, Hartiala JJ, Jalkanen S, Raitakari OT. Pravastatin-induced improvement in coronary reactivity and circulating ATP and ADP levels in young adults with type 1 diabetes. Frontiers in Physiology. 3: 338. PMID 22934084 DOI: 10.3389/fphys.2012.00338  0.64
2012 Salmi M, Jalkanen S. Host CD73 impairs anti-tumor immunity. Oncoimmunology. 1: 247-248. PMID 22720259 DOI: 10.4161/onci.1.2.18310  1
2012 Yegutkin GG, Wieringa B, Robson SC, Jalkanen S. Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 3875-83. PMID 22637533 DOI: 10.1096/fj.12-205658  0.8
2012 Keuschnigg J, Tvorogov D, Elima K, Salmi M, Alitalo K, Salminen T, Jalkanen S. PV-1 is recognized by the PAL-E antibody and forms complexes with NRP-1. Blood. 120: 232-5. PMID 22627768 DOI: 10.1182/blood-2012-01-406876  0.8
2012 Shetty S, Bruns T, Weston CJ, Stamataki Z, Oo YH, Long HM, Reynolds GM, Pratt G, Moss P, Jalkanen S, Hubscher SG, Lalor PF, Adams DH. Recruitment mechanisms of primary and malignant B cells to the human liver. Hepatology (Baltimore, Md.). 56: 1521-31. PMID 22508288 DOI: 10.1002/hep.25790  0.8
2012 Sihto H, Böhling T, Kavola H, Koljonen V, Salmi M, Jalkanen S, Joensuu H. Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2872-81. PMID 22467679 DOI: 10.1158/1078-0432.CCR-11-3020  1
2012 Salmi M, Jalkanen S. Ectoenzymes controlling leukocyte traffic. European Journal of Immunology. 42: 284-92. PMID 22359101 DOI: 10.1002/eji.201142223  1
2012 Aalto K, Maksimow M, Juonala M, Viikari J, Jula A, Kähönen M, Jalkanen S, Raitakari OT, Salmi M. Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early atherosclerotic manifestations Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 523-532. PMID 22116093 DOI: 10.1161/ATVBAHA.111.238030  0.8
2012 Mercier N, Kiviniemi TO, Saraste A, Miiluniemi M, Silvola J, Jalkanen S, Yegutkin GG. Impaired ATP-induced coronary blood flow and diminished aortic NTPDase activity precede lesion formation in apolipoprotein E-deficient mice. The American Journal of Pathology. 180: 419-28. PMID 22074736 DOI: 10.1016/j.ajpath.2011.10.002  0.88
2012 Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundström J, Salmi M, Ristamäki R, Jalkanen S. Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. International Journal of Cancer. 131: 864-73. PMID 21952788 DOI: 10.1002/ijc.26457  1
2011 Autio A, Henttinen T, Sipilä HJ, Jalkanen S, Roivainen A. Mini-PEG spacering of VAP-1-targeting 68Ga-DOTAVAP-P1 peptide improves PET imaging of inflammation. Ejnmmi Research. 1: 10. PMID 22214508 DOI: 10.1186/2191-219X-1-10  0.76
2011 Yegutkin GG, Helenius M, Kaczmarek E, Burns N, Jalkanen S, Stenmark K, Gerasimovskaya EV. Chronic hypoxia impairs extracellular nucleotide metabolism and barrier function in pulmonary artery vasa vasorum endothelial cells. Angiogenesis. 14: 503-13. PMID 21922294 DOI: 10.1007/s10456-011-9234-0  0.8
2011 Aalto K, Autio A, Kiss EA, Elima K, Nymalm Y, Veres TZ, Marttila-Ichihara F, Elovaara H, Saanijoki T, Crocker PR, Maksimow M, Bligt E, Salminen TA, Salmi M, Roivainen A, ... Jalkanen S, et al. Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer. Blood. 118: 3725-33. PMID 21821708 DOI: 10.1182/blood-2010-09-311076  1
2011 Elovaara H, Kidron H, Parkash V, Nymalm Y, Bligt E, Ollikka P, Smith DJ, Pihlavisto M, Salmi M, Jalkanen S, Salminen TA. Identification of two imidazole binding sites and key residues for substrate specificity in human primary amine oxidase AOC3. Biochemistry. 50: 5507-20. PMID 21585208 DOI: 10.1021/bi200117z  1
2011 Salmi M, Jalkanen S. Homing-associated molecules CD73 and VAP-1 as targets to prevent harmful inflammations and cancer spread. Febs Letters. 585: 1543-50. PMID 21515268 DOI: 10.1016/j.febslet.2011.04.033  1
2011 Palani S, Maksimow M, Miiluniemi M, Auvinen K, Jalkanen S, Salmi M. Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages European Journal of Immunology. 41: 2052-2063. PMID 21480214 DOI: 10.1002/eji.201041376  0.8
2011 Yegutkin GG, Marttila-Ichihara F, Karikoski M, Niemelä J, Laurila JP, Elima K, Jalkanen S, Salmi M. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression. European Journal of Immunology. 41: 1231-41. PMID 21469131 DOI: 10.1002/eji.201041292  1
2011 Shetty S, Weston CJ, Oo YH, Westerlund N, Stamataki Z, Youster J, Hubscher SG, Salmi M, Jalkanen S, Lalor PF, Adams DH. Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium. Journal of Immunology (Baltimore, Md. : 1950). 186: 4147-55. PMID 21368224 DOI: 10.4049/jimmunol.1002961  1
2011 Ålgars A, Karikoski M, Yegutkin GG, Stoitzner P, Niemelä J, Salmi M, Jalkanen S. Different role of CD73 in leukocyte trafficking via blood and lymph vessels. Blood. 117: 4387-93. PMID 21346249 DOI: 10.1182/blood-2010-11-321646  1
2011 Hänninen A, Maksimow M, Alam C, Morgan DJ, Jalkanen S. Ly6C supports preferential homing of central memory CD8+ T cells into lymph nodes. European Journal of Immunology. 41: 634-44. PMID 21308682 DOI: 10.1002/eji.201040760  1
2011 Liaskou E, Karikoski M, Reynolds GM, Lalor PF, Weston CJ, Pullen N, Salmi M, Jalkanen S, Adams DH. Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity Hepatology. 53: 661-672. PMID 21225644 DOI: 10.1002/hep.24085  0.8
2010 Yegutkin GG, Hytönen J, Samburski SS, Yrjänäinen H, Jalkanen S, Viljanen MK. Disordered lymphoid purine metabolism contributes to the pathogenesis of persistent Borrelia garinii infection in mice. Journal of Immunology (Baltimore, Md. : 1950). 184: 5112-20. PMID 20357256 DOI: 10.4049/jimmunol.0902760  0.64
2010 Marttila-Ichihara F, Castermans K, Auvinen K, Oude Egbrink MG, Jalkanen S, Griffioen AW, Salmi M. Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice. Journal of Immunology (Baltimore, Md. : 1950). 184: 3164-73. PMID 20154208 DOI: 10.4049/jimmunol.0901794  1
2010 Puputti M, Tynninen O, Pernilä P, Salmi M, Jalkanen S, Paetau A, Sihto H, Joensuu H. Expression of KIT receptor tyrosine kinase in endothelial cells of juvenile brain tumors. Brain Pathology (Zurich, Switzerland). 20: 763-70. PMID 20030644 DOI: 10.1111/j.1750-3639.2009.00357.x  1
2009 Kivi E, Elima K, Aalto K, Nymalm Y, Auvinen K, Koivunen E, Otto DM, Crocker PR, Salminen TA, Salmi M, Jalkanen S. Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate. Blood. 114: 5385-92. PMID 19861682 DOI: 10.1182/blood-2009-04-219253  1
2009 Karikoski M, Irjala H, Maksimow M, Miiluniemi M, Granfors K, Hernesniemi S, Elima K, Moldenhauer G, Schledzewski K, Kzhyshkowska J, Goerdt S, Salmi M, Jalkanen S. Clever-1/Stabilin-1 regulates lymphocyte migration within lymphatics and leukocyte entrance to sites of inflammation. European Journal of Immunology. 39: 3477-87. PMID 19830743 DOI: 10.1002/eji.200939896  1
2009 Marttila-Ichihara F, Auvinen K, Elima K, Jalkanen S, Salmi M. Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors. Cancer Research. 69: 7875-83. PMID 19789345 DOI: 10.1158/0008-5472.CAN-09-1205  1
2009 Zhang J, Gratchev A, Riabov V, Mamidi S, Schmuttermaier C, Krusell L, Kremmer E, Workman G, Sage EH, Jalkanen S, Goerdt S, Kzhyshkowska J. A novel GGA-binding site is required for intracellular sorting mediated by stabilin-1. Molecular and Cellular Biology. 29: 6097-105. PMID 19752197 DOI: 10.1128/MCB.00505-09  0.8
2009 Ujula T, Salomäki S, Virsu P, Lankinen P, Mäkinen TJ, Autio A, Yegutkin GG, Knuuti J, Jalkanen S, Roivainen A. Synthesis, 68Ga labeling and preliminary evaluation of DOTA peptide binding vascular adhesion protein-1: a potential PET imaging agent for diagnosing osteomyelitis. Nuclear Medicine and Biology. 36: 631-41. PMID 19647169 DOI: 10.1016/j.nucmedbio.2009.04.008  0.64
2009 Kaitaniemi S, Elovaara H, Grön K, Kidron H, Liukkonen J, Salminen T, Salmi M, Jalkanen S, Elima K. The unique substrate specificity of human AOC2, a semicarbazide-sensitive amine oxidase. Cellular and Molecular Life Sciences : Cmls. 66: 2743-57. PMID 19588076 DOI: 10.1007/s00018-009-0076-5  1
2009 Peltola K, Hollmen M, Maula SM, Rainio E, Ristamäki R, Luukkaa M, Sandholm J, Sundvall M, Elenius K, Koskinen PJ, Grenman R, Jalkanen S. Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor. Neoplasia (New York, N.Y.). 11: 629-36. PMID 19568408 DOI: 10.1593/neo.81038  0.56
2009 Keuschnigg J, Henttinen T, Auvinen K, Karikoski M, Salmi M, Jalkanen S. The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. Blood. 114: 478-84. PMID 19420356 DOI: 10.1182/blood-2008-11-188763  1
2009 Bour S, Caspar-Bauguil S, Iffiú-Soltész Z, Nibbelink M, Cousin B, Miiluniemi M, Salmi M, Stolen C, Jalkanen S, Casteilla L, Pénicaud L, Valet P, Carpéné C. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 deficiency reduces leukocyte infiltration into adipose tissue and favors fat deposition. The American Journal of Pathology. 174: 1075-83. PMID 19218346 DOI: 10.2353/ajpath.2009.080612  1
2008 Kiss J, Jalkanen S, Fülöp F, Savunen T, Salmi M. Ischemia-reperfusion injury is attenuated in VAP-1-deficient mice and by VAP-1 inhibitors. European Journal of Immunology. 38: 3041-9. PMID 18991279 DOI: 10.1002/eji.200838651  1
2008 Niemelä J, Ifergan I, Yegutkin GG, Jalkanen S, Prat A, Airas L. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier. European Journal of Immunology. 38: 2718-26. PMID 18825744 DOI: 10.1002/eji.200838437  0.8
2008 Mills JH, Thompson LF, Mueller C, Waickman AT, Jalkanen S, Niemela J, Airas L, Bynoe MS. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. 105: 9325-30. PMID 18591671 DOI: 10.1073/pnas.0711175105  0.48
2008 Yegutkin GG, Jankowski J, Jalkanen S, Günthner T, Zidek W, Jankowski V. Dinucleotide polyphosphates contribute to purinergic signalling via inhibition of adenylate kinase activity. Bioscience Reports. 28: 189-94. PMID 18576946 DOI: 10.1042/BSR20080052  0.64
2008 Mikhailov A, Sokolovskaya A, Yegutkin GG, Amdahl H, West A, Yagita H, Lahesmaa R, Thompson LF, Jalkanen S, Blokhin D, Eriksson JE. CD73 participates in cellular multiresistance program and protects against TRAIL-induced apoptosis. Journal of Immunology (Baltimore, Md. : 1950). 181: 464-75. PMID 18566412  0.68
2008 Marttila-Ichihara F, Turja R, Miiluniemi M, Karikoski M, Maksimow M, Niemelä J, Martinez-Pomares L, Salmi M, Jalkanen S. Macrophage mannose receptor on lymphatics controls cell trafficking. Blood. 112: 64-72. PMID 18434610 DOI: 10.1182/blood-2007-10-118984  1
2008 Jalkanen S, Salmi M. VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arteriosclerosis, Thrombosis, and Vascular Biology. 28: 18-26. PMID 17962625 DOI: 10.1161/ATVBAHA.107.153130  1
2008 Ruotsalainen E, Vauhkonen I, Salmenniemi U, Pihlajamäki J, Punnonen K, Kainulainen S, Jalkanen S, Salmi M, Laakso M. Markers of endothelial dysfunction and low-grade inflammation are associated in the offspring of type 2 diabetic subjects. Atherosclerosis. 197: 271-7. PMID 17560580 DOI: 10.1016/j.atherosclerosis.2007.04.021  1
2007 Kiss J, Yegutkin GG, Koskinen K, Savunen T, Jalkanen S, Salmi M. IFN-beta protects from vascular leakage via up-regulation of CD73. European Journal of Immunology. 37: 3334-8. PMID 18034430 DOI: 10.1002/eji.200737793  1
2007 Airas L, Lindsberg PJ, Karjalainen-Lindsberg ML, Mononen I, Kotisaari K, Smith DJ, Jalkanen S. Vascular adhesion protein-1 in human ischaemic stroke. Neuropathology and Applied Neurobiology. 34: 394-402. PMID 18005095 DOI: 10.1111/j.1365-2990.2007.00911.x  0.4
2007 Koskinen K, Nevalainen S, Karikoski M, Hänninen A, Jalkanen S, Salmi M. VAP-1-deficient mice display defects in mucosal immunity and antimicrobial responses: implications for antiadhesive applications. Journal of Immunology (Baltimore, Md. : 1950). 179: 6160-8. PMID 17947691 DOI: 10.4049/jimmunol.179.9.6160  1
2007 Airas L, Niemelä J, Yegutkin G, Jalkanen S. Mechanism of action of IFN-beta in the treatment of multiple sclerosis: a special reference to CD73 and adenosine. Annals of the New York Academy of Sciences. 1110: 641-8. PMID 17911479 DOI: 10.1196/annals.1423.067  0.64
2007 Jalkanen S, Karikoski M, Mercier N, Koskinen K, Henttinen T, Elima K, Salmivirta K, Salmi M. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood. 110: 1864-70. PMID 17548577 DOI: 10.1182/blood-2007-01-069674  1
2007 Bour S, Prévot D, Guigné C, Stolen C, Jalkanen S, Valet P, Carpéné C. Semicarbazide-sensitive amine oxidase substrates fail to induce insulin-like effects in fat cells from AOC3 knockout mice. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 829-33. PMID 17406965 DOI: 10.1007/s00702-007-0671-2  0.4
2007 Yegutkin GG, Samburski SS, Mortensen SP, Jalkanen S, González-Alonso J. Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans. The Journal of Physiology. 579: 553-64. PMID 17204504 DOI: 10.1113/jphysiol.2006.119453  0.64
2007 Hänninen A, Nurmela R, Maksimow M, Heino J, Jalkanen S, Kurts C. Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets. The American Journal of Pathology. 170: 240-50. PMID 17200197 DOI: 10.2353/ajpath.2007.060142  1
2006 Marttila-Ichihara F, Smith DJ, Stolen C, Yegutkin GG, Elima K, Mercier N, Kiviranta R, Pihlavisto M, Alaranta S, Pentikäinen U, Pentikäinen O, Fülöp F, Jalkanen S, Salmi M. Vascular amine oxidases are needed for leukocyte extravasation into inflamed joints in vivo. Arthritis and Rheumatism. 54: 2852-62. PMID 16947396 DOI: 10.1002/art.22061  1
2006 Yegutkin GG, Samburski SS, Jalkanen S, Novak I. ATP-consuming and ATP-generating enzymes secreted by pancreas. The Journal of Biological Chemistry. 281: 29441-7. PMID 16885159 DOI: 10.1074/jbc.M602480200  0.64
2006 Yegutkin GG, Mikhailov A, Samburski SS, Jalkanen S. The detection of micromolar pericellular ATP pool on lymphocyte surface by using lymphoid ecto-adenylate kinase as intrinsic ATP sensor. Molecular Biology of the Cell. 17: 3378-85. PMID 16707571 DOI: 10.1091/mbc.e05-10-0993  0.64
2006 Maksimow M, Miiluniemi M, Marttila-Ichihara F, Jalkanen S, Hänninen A. Antigen targeting to endosomal pathway in dendritic cell vaccination activates regulatory T cells and attenuates tumor immunity. Blood. 108: 1298-305. PMID 16621963 DOI: 10.1182/blood-2005-11-008615  1
2006 Salmi M, Jalkanen S. Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans. Blood. 108: 1555-61. PMID 16556889 DOI: 10.1182/blood-2005-11-4599  1
2006 Yu PH, Lu LX, Fan H, Kazachkov M, Jiang ZJ, Jalkanen S, Stolen C. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation. The American Journal of Pathology. 168: 718-26. PMID 16507887 DOI: 10.2353/ajpath.2006.050970  0.8
2006 Lautamäki R, Borra R, Iozzo P, Komu M, Lehtimäki T, Salmi M, Jalkanen S, Airaksinen KE, Knuuti J, Parkkola R, Nuutila P. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. American Journal of Physiology. Endocrinology and Metabolism. 291: E282-90. PMID 16478772 DOI: 10.1152/ajpendo.00604.2005  1
2006 Nieminen M, Henttinen T, Merinen M, Marttila-Ichihara F, Eriksson JE, Jalkanen S. Vimentin function in lymphocyte adhesion and transcellular migration. Nature Cell Biology. 8: 156-62. PMID 16429129 DOI: 10.1038/ncb1355  0.88
2006 Maksimow M, Söderström TS, Jalkanen S, Eriksson JE, Hänninen A. Fas costimulation of naive CD4 T cells is controlled by NF-kappaB signaling and caspase activity. Journal of Leukocyte Biology. 79: 369-77. PMID 16330535 DOI: 10.1189/jlb.0505238  1
2005 Kirton CM, Laukkanen ML, Nieminen A, Merinen M, Stolen CM, Armour K, Smith DJ, Salmi M, Jalkanen S, Clark MR. Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy. European Journal of Immunology. 35: 3119-30. PMID 16224816 DOI: 10.1002/eji.200535300  1
2005 Salmi M, Jalkanen S. Cell-surface enzymes in control of leukocyte trafficking. Nature Reviews. Immunology. 5: 760-71. PMID 16200079 DOI: 10.1038/nri1705  1
2005 Bonder CS, Norman MU, Swain MG, Zbytnuik LD, Yamanouchi J, Santamaria P, Ajuebor M, Salmi M, Jalkanen S, Kubes P. Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1. Immunity. 23: 153-63. PMID 16111634 DOI: 10.1016/j.immuni.2005.06.007  1
2005 Niemelä H, Elima K, Henttinen T, Irjala H, Salmi M, Jalkanen S. Molecular identification of PAL-E, a widely used endothelial-cell marker. Blood. 106: 3405-9. PMID 16099878 DOI: 10.1182/blood-2005-01-0254  1
2005 Salmi M, Jalkanen S. Lymphocyte homing to the gut: attraction, adhesion, and commitment. Immunological Reviews. 206: 100-13. PMID 16048544 DOI: 10.1111/j.0105-2896.2005.00285.x  1
2005 Airenne TT, Nymalm Y, Kidron H, Smith DJ, Pihlavisto M, Salmi M, Jalkanen S, Johnson MS, Salminen TA. Crystal structure of the human vascular adhesion protein-1: unique structural features with functional implications. Protein Science : a Publication of the Protein Society. 14: 1964-74. PMID 16046623 DOI: 10.1110/ps.051438105  1
2005 Merinen M, Irjala H, Salmi M, Jaakkola I, Hänninen A, Jalkanen S. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. The American Journal of Pathology. 166: 793-800. PMID 15743791 DOI: 10.1016/S0002-9440(10)62300-0  1
2005 Stolen CM, Marttila-Ichihara F, Koskinen K, Yegutkin GG, Turja R, Bono P, Skurnik M, Hänninen A, Jalkanen S, Salmi M. Absence of the endothelial oxidase AOC3 leads to abnormal leukocyte traffic in vivo. Immunity. 22: 105-15. PMID 15664163 DOI: 10.1016/j.immuni.2004.12.006  1
2004 Martelius T, Salaspuro V, Salmi M, Krogerus L, Höckerstedt K, Jalkanen S, Lautenschlager I. Blockade of vascular adhesion protein-1 inhibits lymphocyte infiltration in rat liver allograft rejection. The American Journal of Pathology. 165: 1993-2001. PMID 15579442 DOI: 10.1016/S0002-9440(10)63250-6  1
2004 Salmi M, Koskinen K, Henttinen T, Elima K, Jalkanen S. CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium. Blood. 104: 3849-57. PMID 15297319 DOI: 10.1182/blood-2004-01-0222  1
2004 Yegutkin GG, Salminen T, Koskinen K, Kurtis C, McPherson MJ, Jalkanen S, Salmi M. A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress. European Journal of Immunology. 34: 2276-85. PMID 15259025 DOI: 10.1002/eji.200424932  1
2004 Stolen CM, Yegutkin GG, Kurkijärvi R, Bono P, Alitalo K, Jalkanen S. Origins of serum semicarbazide-sensitive amine oxidase. Circulation Research. 95: 50-7. PMID 15178639 DOI: 10.1161/01.RES.0000134630.68877.2F  0.64
2004 Stolen CM, Madanat R, Marti L, Kari S, Yegutkin GG, Sariola H, Zorzano A, Jalkanen S. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 702-4. PMID 14977883 DOI: 10.1096/fj.03-0562fje  0.64
2004 Niemelä J, Henttinen T, Yegutkin GG, Airas L, Kujari AM, Rajala P, Jalkanen S. IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation. Journal of Immunology (Baltimore, Md. : 1950). 172: 1646-53. PMID 14734746 DOI: 10.4049/jimmunol.172.3.1646  0.76
2004 Koskinen K, Vainio PJ, Smith DJ, Pihlavisto M, Ylä-Herttuala S, Jalkanen S, Salmi M. Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1). Blood. 103: 3388-95. PMID 14726375 DOI: 10.1182/blood-2003-09-3275  1
2003 Jaakkola I, Jalkanen S, Hänninen A. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice. European Journal of Immunology. 33: 3255-64. PMID 14635033 DOI: 10.1002/eji.200324405  0.88
2003 Henttinen T, Jalkanen S, Yegutkin GG. Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by Ecto-5'-nucleotidase/CD73-dependent mechanism. The Journal of Biological Chemistry. 278: 24888-95. PMID 12707258 DOI: 10.1074/JBC.M300779200  0.32
2003 Irjala H, Elima K, Johansson EL, Merinen M, Kontula K, Alanen K, Grenman R, Salmi M, Jalkanen S. The same endothelial receptor controls lymphocyte traffic both in vascular and lymphatic vessels. European Journal of Immunology. 33: 815-24. PMID 12616502 DOI: 10.1002/eji.200323859  1
2003 Jaakkola I, Merinen M, Jalkanen S, Hänninen A. Ly6C induces clustering of LFA-1 (CD11a/CD18) and is involved in subtype-specific adhesion of CD8 T cells. Journal of Immunology (Baltimore, Md. : 1950). 170: 1283-90. PMID 12538687 DOI: 10.4049/jimmunol.170.3.1283  0.88
2003 Maksimow M, Santanen M, Jalkanen S, Hänninen A. Responding naive T cells differ in their sensitivity to Fas engagement: early death of many T cells is compensated by costimulation of surviving T cells. Blood. 101: 4022-8. PMID 12531803 DOI: 10.1182/blood-2002-06-1904  1
2002 Salmi M, Stolen C, Jousilahti P, Yegutkin GG, Tapanainen P, Janatuinen T, Knip M, Jalkanen S, Salomaa V. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes. The American Journal of Pathology. 161: 2255-62. PMID 12466139 DOI: 10.1016/S0002-9440(10)64501-4  1
2002 Lalor PF, Edwards S, McNab G, Salmi M, Jalkanen S, Adams DH. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. Journal of Immunology (Baltimore, Md. : 1950). 169: 983-92. PMID 12097405 DOI: 10.4049/jimmunol.169.2.983  1
2002 Blades MC, Manzo A, Ingegnoli F, Taylor PR, Panayi GS, Irjala H, Jalkanen S, Haskard DO, Perretti M, Pitzalis C. Stromal cell-derived factor 1 (CXCL12) induces human cell migration into human lymph nodes transplanted into SCID mice. Journal of Immunology (Baltimore, Md. : 1950). 168: 4308-17. PMID 11970972  0.56
2002 Grant AJ, Lalor PF, Salmi M, Jalkanen S, Adams DH. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet (London, England). 359: 150-7. PMID 11809275 DOI: 10.1016/S0140-6736(02)07374-9  1
2001 Salmi M, Alanen K, Grenman S, Briskin M, Butcher EC, Jalkanen S. Immune cell trafficking in uterus and early life is dominated by the mucosal addressin MAdCAM-1 in humans. Gastroenterology. 121: 853-64. PMID 11606499 DOI: 10.1053/gast.2001.27968  0.44
2001 Irjala H, Johansson EL, Grenman R, Alanen K, Salmi M, Jalkanen S. Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. The Journal of Experimental Medicine. 194: 1033-42. PMID 11602634 DOI: 10.1084/JEM.194.8.1033  0.6
2001 Jalkanen K, Leu T, Bono P, Salmi M, Jalkanen S, Smith DJ. Distinct ligand binding properties of Mac-2-binding protein and mouse cyclophilin [correction of mousephilin] C-associated protein. European Journal of Immunology. 31: 3075-84. PMID 11592084 DOI: 10.1002/1521-4141(2001010)31:10<3075::AID-IMMU3075>3.0.CO;2-D  0.32
2001 Kurkijärvi R, Jalkanen S, Isoniemi H, Salmi M. Vascular adhesion protein-1 (VAP-1) mediates lymphocyte-endothelial interactions in chronic kidney rejection. European Journal of Immunology. 31: 2876-84. PMID 11592062 DOI: 10.1002/1521-4141(2001010)31:10<2876::AID-IMMU2876>3.0.CO;2-Z  0.64
2001 Jalkanen S, Salmi M. Cell surface monoamine oxidases: enzymes in search of a function. The Embo Journal. 20: 3893-901. PMID 11483492 DOI: 10.1093/emboj/20.15.3893  0.64
2001 Irjala H, Salmi M, Alanen K, Grénman R, Jalkanen S. Vascular adhesion protein 1 mediates binding of immunotherapeutic effector cells to tumor endothelium. Journal of Immunology (Baltimore, Md. : 1950). 166: 6937-43. PMID 11359855 DOI: 10.4049/jimmunol.166.11.6937  0.36
2001 Salmi M, Yegutkin GG, Lehvonen R, Koskinen K, Salminen T, Jalkanen S. A cell surface amine oxidase directly controls lymphocyte migration. Immunity. 14: 265-76. PMID 11290336 DOI: 10.1016/S1074-7613(01)00108-X  0.4
2001 Salmi M, Jalkanen S. VAP-1: an adhesin and an enzyme. Trends in Immunology. 22: 211-6. PMID 11274927 DOI: 10.1016/S1471-4906(01)01870-1  0.72
2001 Salmi M, Jalkanen S. Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. Journal of Immunology (Baltimore, Md. : 1950). 166: 4650-7. PMID 11254724 DOI: 10.4049/jimmunol.166.7.4650  0.72
2001 Tohka S, Laukkanen M, Jalkanen S, Salmi M. Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 373-82. PMID 11156953 DOI: 10.1096/fj.00-0240com  0.52
2000 Kurkijärvi R, Yegutkin GG, Gunson BK, Jalkanen S, Salmi M, Adams DH. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology. 119: 1096-103. PMID 11040196 DOI: 10.1053/GAST.2000.18163  0.6
2000 Martelius T, Salmi M, Wu H, Bruggeman C, Höckerstedt K, Jalkanen S, Lautenschlager I. Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats. The American Journal of Pathology. 157: 1229-37. PMID 11021827 DOI: 10.1016/S0002-9440(10)64638-X  0.4
2000 Jaakkola K, Jalkanen S, Kaunismäki K, Vänttinen E, Saukko P, Alanen K, Kallajoki M, Voipio-Pulkki LM, Salmi M. Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans. Journal of the American College of Cardiology. 36: 122-9. PMID 10898423 DOI: 10.1016/S0735-1097(00)00706-3  0.44
2000 Salmi M, Tohka S, Jalkanen S. Human vascular adhesion protein-1 (VAP-1) plays a critical role in lymphocyte-endothelial cell adhesion cascade under shear. Circulation Research. 86: 1245-51. PMID 10864915 DOI: 10.1161/01.RES.86.12.1245  0.68
1999 Jaakkola K, Kaunismäki K, Tohka S, Yegutkin G, Vänttinen E, Havia T, Pelliniemi LJ, Virolainen M, Jalkanen S, Salmi M. Human vascular adhesion protein-1 in smooth muscle cells. The American Journal of Pathology. 155: 1953-65. PMID 10595925 DOI: 10.1016/S0002-9440(10)65514-9  0.44
1999 Bono P, Jalkanen S, Salmi M. Mouse vascular adhesion protein 1 is a sialoglycoprotein with enzymatic activity and is induced in diabetic insulitis. The American Journal of Pathology. 155: 1613-24. PMID 10550318 DOI: 10.1016/S0002-9440(10)65477-6  1
1999 Salmi M, Jalkanen S. Molecules controlling lymphocyte migration to the gut. Gut. 45: 148-53. PMID 10369720 DOI: 10.1136/gut.45.1.148  0.68
1998 Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. The Journal of Experimental Medicine. 188: 17-27. PMID 9653080 DOI: 10.1084/jem.188.1.17  0.8
1998 Salmi M, Jalkanen S. Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD. Inflammatory Bowel Diseases. 4: 149-56. PMID 9589300 DOI: 10.1002/IBD.3780040210  0.72
1997 Salmi M, Smith DJ, Bono P, Leu T, Hellman J, Matikainen MT, Jalkanen S. A mouse molecular mimic of human vascular adhesion protein-1. Molecular Immunology. 34: 1227-36. PMID 9566769 DOI: 10.1016/S0161-5890(97)00060-6  0.8
1997 Salmi M, Tohka S, Berg EL, Butcher EC, Jalkanen S. Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype- specific, selectin-independent recognition of vascular endothelium in human lymph nodes Journal of Experimental Medicine. 186: 589-600. PMID 9254657 DOI: 10.1084/jem.186.4.589  0.8
1997 Arvilommi AM, Salmi M, Jalkanen S. Organ-selective regulation of vascular adhesion protein-1 expression in man. European Journal of Immunology. 27: 1794-800. PMID 9247594 DOI: 10.1002/EJI.1830270730  0.6
1997 Hänninen A, Jaakkola I, Salmi M, Simell O, Jalkanen S. Ly-6C regulates endothelial adhesion and homing of CD8(+) T cells by activating integrin-dependent adhesion pathways. Proceedings of the National Academy of Sciences of the United States of America. 94: 6898-903. PMID 9192663 DOI: 10.1073/PNAS.94.13.6898  0.6
1997 Salmi M, Rajala P, Jalkanen S. Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion. The Journal of Clinical Investigation. 99: 2165-72. PMID 9151788 DOI: 10.1172/JCI119389  0.44
1997 Aho R, Kalimo H, Salmi M, Smith D, Jalkanen S. Binding of malignant lymphoid cells to the white matter of the human central nervous system: role of different CD44 isoforms, beta 1, beta 2 and beta 7 integrins, and L-selectin. Journal of Neuropathology and Experimental Neurology. 56: 557-68. PMID 9143269 DOI: 10.1097/00005072-199705000-00012  0.8
1997 Salmi M, Jalkanen S. How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Advances in Immunology. 64: 139-218. PMID 9100982 DOI: 10.1016/S0065-2776(08)60889-5  0.44
1997 Arvilommi AM, Salmi M, Airas L, Kalimo K, Jalkanen S. CD73 mediates lymphocyte binding to vascular endothelium in inflamed human skin. European Journal of Immunology. 27: 248-54. PMID 9022026 DOI: 10.1002/EJI.1830270137  0.72
1997 Airas L, Niemelä J, Salmi M, Puurunen T, Smith DJ, Jalkanen S. Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. The Journal of Cell Biology. 136: 421-31. PMID 9015312 DOI: 10.1083/JCB.136.2.421  0.44
1996 Hänninen A, Salmi M, Simell O, Jalkanen S. Mucosa-associated (beta 7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior. Diabetes. 45: 1173-80. PMID 8772718 DOI: 10.2337/diab.45.9.1173  0.52
1996 Salmi M, Jalkanen S. Human vascular adhesion protein 1 (VAP-1) is a unique sialoglycoprotein that mediates carbohydrate-dependent binding of lymphocytes to endothelial cells. The Journal of Experimental Medicine. 183: 569-79. PMID 8627168 DOI: 10.1084/JEM.183.2.569  0.68
1996 Arvilommi AM, Salmi M, Kalimo K, Jalkanen S. Lymphocyte binding to vascular endothelium in inflamed skin revisited: a central role for vascular adhesion protein-1 (VAP-1). European Journal of Immunology. 26: 825-33. PMID 8625974 DOI: 10.1002/EJI.1830260415  0.76
1996 Kantele JM, Arvilommi H, Kontiainen S, Salmi M, Jalkanen S, Savilahti E, Westerholm M, Kantele A. Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology. 110: 1061-7. PMID 8612994 DOI: 10.1053/GAST.1996.V110.PM8612994  0.4
1996 McNab G, Reeves JL, Salmi M, Hubscher S, Jalkanen S, Adams DH. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium Gastroenterology. 110: 522-528. PMID 8566600 DOI: 10.1053/gast.1996.v110.pm8566600  0.8
1996 Hanninen A, Salmi M, Simell O, Andrew D, Jalkanen S. Recirculation and homing of lymphocyte subsets: dual homing specificity of beta 7-integrin(high)-lymphocytes in nonobese diabetic mice Blood. 88: 934-944. DOI: 10.1182/BLOOD.V88.3.934.BLOODJOURNAL883934  0.32
1995 Airas L, Hellman J, Salmi M, Bono P, Puurunen T, Smith DJ, Jalkanen S. CD73 is involved in lymphocyte binding to the endothelium: Characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73 Journal of Experimental Medicine. 182: 1603-1608. PMID 7595232 DOI: 10.1084/jem.182.5.1603  0.8
1995 Salmi M, Jalkanen S. Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models. European Journal of Immunology. 25: 2803-12. PMID 7589075 DOI: 10.1002/EJI.1830251014  0.8
1995 Salmi M, Andrew DP, Butcher EC, Jalkanen S. Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms. The Journal of Experimental Medicine. 181: 137-49. PMID 7528765 DOI: 10.1084/jem.181.1.137  0.56
1994 Jalkanen S, Salmi M. Vascular adhesion protein-1 (VAP-1)--a new adhesion molecule recruiting lymphocytes to sites of inflammation. Research in Immunology. 144: 746-9; discussion 75. PMID 8159873 DOI: 10.1016/0923-2494(93)80060-C  0.6
1994 Salmi M, Granfors K, MacDermott R, Jalkanen S. Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases. Gastroenterology. 106: 596-605. PMID 8119529 DOI: 10.1016/0016-5085(94)90691-2  0.4
1994 Aho R, Jalkanen S, Kalimo H. CD44-hyaluronate interaction mediates in vitro lymphocyte binding to the white matter of the central nervous system. Journal of Neuropathology and Experimental Neurology. 53: 295-302. PMID 7513749 DOI: 10.1097/00005072-199405000-00011  0.56
1994 Ristamaki R, Joensuu H, Salmi M, Jalkanen S. Serum CD44 in malignant lymphoma: an association with treatment response Blood. 84: 238-243. DOI: 10.1182/BLOOD.V84.1.238.BLOODJOURNAL841238  0.32
1993 Hänninen A, Salmi M, Simell O, Jalkanen S. Endothelial cell-binding properties of lymphocytes infiltrated into human diabetic pancreas. Implications for pathogenesis of IDDM. Diabetes. 42: 1656-62. PMID 8405709 DOI: 10.2337/diab.42.11.1656  0.44
1993 Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. The Journal of Cell Biology. 122: 431-42. PMID 8320265 DOI: 10.1083/JCB.122.2.431  1
1993 Salmi M, Kalimo K, Jalkanen S. Induction and function of vascular adhesion protein-1 at sites of inflammation. The Journal of Experimental Medicine. 178: 2255-60. PMID 8245796 DOI: 10.1084/JEM.178.6.2255  0.6
1992 Jalkanen S. Lymphocyte traffic to mucosa-associated lymphatic tissues. Immunologic Research. 10: 268-70. PMID 1955753 DOI: 10.1007/BF02919705  0.36
1992 Salmi M, Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science (New York, N.Y.). 257: 1407-9. PMID 1529341 DOI: 10.1126/SCIENCE.1529341  0.64
1992 Hänninen A, Jalkanen S, Salmi M, Toikkanen S, Nikolakaros G, Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. The Journal of Clinical Investigation. 90: 1901-10. PMID 1385478 DOI: 10.1172/JCI116067  0.48
1992 Salmi M, Jalkanen S. Regulation of L-selectin expression on cultured bone marrow leukocytes and their precursors. European Journal of Immunology. 22: 835-43. PMID 1372261 DOI: 10.1002/EJI.1830220331  0.68
1990 Jalkanen S. Lymphocyte homing into the gut. Springer Seminars in Immunopathology. 12: 153-64. PMID 2205937 DOI: 10.1007/BF00197503  0.32
1990 Jalkanen S, Saari S, Kalimo H, Lammintausta K, Vainio E, Leino R, Duijvestijn AM, Kalimo K. Lymphocyte migration into the skin: the role of lymphocyte homing receptor (CD44) and endothelial cell antigen (HECA-452). The Journal of Investigative Dermatology. 94: 786-92. PMID 1693939 DOI: 10.1111/1523-1747.EP12874646  0.56
1989 Jalkanen S, Bargatze R, Jalkanen M, Lewinsohn D, Streeter P, Lakey E, Butcher EC. Lymphocyte migration molecules. Advances in Experimental Medicine and Biology. 237: 21-9. PMID 2855387 DOI: 10.1007/978-1-4684-5535-9_3  0.56
1989 Jalkanen S. Leukocyte-endothelial cell interaction and the control of leukocyte migration into inflamed synovium. Springer Seminars in Immunopathology. 11: 187-98. PMID 2683162 DOI: 10.1007/BF00197188  0.44
1989 Jalkanen S, Aho R, Kallajoki M, Ekfors T, Nortamo P, Gahmberg C, Duijvestijn A, Kalimo H. Lymphocyte homing receptors and adhesion molecules in intravascular malignant lymphomatosis. International Journal of Cancer. Journal International Du Cancer. 44: 777-82. PMID 2573578 DOI: 10.1002/IJC.2910440505  0.56
1989 Jalkanen S, Nash GS, De los Toyos J, MacDermott RP, Butcher EC. Human lamina propria lymphocytes bear homing receptors and bind selectively to mucosal lymphoid high endothelium. European Journal of Immunology. 19: 63-8. PMID 2465905 DOI: 10.1002/eji.1830190111  0.44
1988 Wu NW, Jalkanen S, Streeter PR, Butcher EC. Evolutionary conservation of tissue-specific lymphocyte-endothelial cell recognition mechanisms involved in lymphocyte homing. The Journal of Cell Biology. 107: 1845-51. PMID 3182939 DOI: 10.1083/jcb.107.5.1845  0.48
1987 Jalkanen S, Wu N, Bargatze RF, Butcher EC. Human lymphocyte and lymphoma homing receptors. Annual Review of Medicine. 38: 467-76. PMID 3555307 DOI: 10.1146/  0.56
1987 Jalkanen S, Bargatze RF, de los Toyos J, Butcher EC. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. The Journal of Cell Biology. 105: 983-90. PMID 2442176 DOI: 10.1083/jcb.105.2.983  0.64
1986 Jalkanen S, Steere AC, Fox RI, Butcher EC. A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science (New York, N.Y.). 233: 556-8. PMID 3726548 DOI: 10.1126/science.3726548  0.32
1986 Butcher EC, Lewinsohn D, Duijvestijn A, Bargatze R, Wu N, Jalkanen S. Interactions between endothelial cells and leukocytes. Journal of Cellular Biochemistry. 30: 121-31. PMID 3517023 DOI: 10.1002/jcb.240300204  0.6
1986 Jalkanen ST, Bargatze RF, Herron LR, Butcher EC. A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. European Journal of Immunology. 16: 1195-202. PMID 2429846 DOI: 10.1002/eji.1830161003  0.68
1985 Navarro RF, Jalkanen ST, Hsu M, Søenderstrup-Hansen G, Goronzy J, Weyand C, Fathman CG, Clayberger C, Krensky AM, Butcher EC. Human T cell clones express functional homing receptors required for normal lymphocyte trafficking Journal of Experimental Medicine. 162: 1075-1080. PMID 3875680 DOI: 10.1084/jem.162.3.1075  0.8
1983 Jalkanen S. Immune capacity of the chicken bursectomized at 60 hours of incubation: transplantation of bone marrow cells of the bursectomized chickens into cyclophosphamide-treated newly hatched recipients. European Journal of Immunology. 13: 779-85. PMID 6604637 DOI: 10.1002/eji.1830130915  0.36
Show low-probability matches.